Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose

Zhalbinova, M.; Rakhimova, S.; Bekbosynova, M.; Myrzakhmetova, Sh.; Akilzhanova, A.

dc.contributor.author	Zhalbinova, M.
dc.contributor.author	Rakhimova, S.
dc.contributor.author	Bekbosynova, M.
dc.contributor.author	Myrzakhmetova, Sh.
dc.contributor.author	Akilzhanova, A.
dc.date.accessioned	2016-05-31T03:37:55Z
dc.date.available	2016-05-31T03:37:55Z
dc.date.issued	2016-05
dc.identifier.citation	M. Zhalbinova, S. Rakhimova, M. Bekbosynova, Sh. Myrzakhmetova, and A. Akilzhanova. 2016. Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose. Abstract book. 4 th International Scientific Conference “Regenerative medicine & healthy aging”. National Laboratory Astana, Nazarbayev University. http://nur.nu.edu.kz/handle/123456789/1533	ru_RU
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/1533
dc.description.abstract	Warfarin is an oral anticoagulant which is popular in cardiology for the prevention and treatment of thromboembolic events in patients with deep vein thrombosis. Patients usually treated according to the clinical data. However, incorrect dose of the treatment can be followed with side effects such as excessive bleeding and thrombosis. To avoid these side effects patients need genetic tests for specific genes which are responsible for the sensitivity of patient to warfarin. GGCX is one of the genes which have a role in dose of the warfarin	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	National Laboratory Astana, NAZARBAYEV UNIVERSITY	ru_RU
dc.rights	Attribution-NonCommercial-ShareAlike 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/us/	*
dc.subject	warfarin	ru_RU
dc.subject	GGCX	ru_RU
dc.subject	anticoagulant	ru_RU
dc.title	Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose	ru_RU
dc.type	Abstract	ru_RU